Phibro Animal Health Corp. A Stock
A loss of -1.890% shows a downward development for Phibro Animal Health Corp. A.
The community is currently still undecided about Phibro Animal Health Corp. A with 1 Buy predictions and 1 Sell predictions.
As a result the target price of 33 € shows a slightly positive potential of 5.77% compared to the current price of 31.2 € for Phibro Animal Health Corp. A.
Pros and Cons of Phibro Animal Health Corp. A in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Phibro Animal Health Corp. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Phibro Animal Health Corp. A | -1.890% | 5.405% | 13.043% | 26.829% | -1.266% | 143.750% | 58.376% |
| Pacira Pharmaceuticals | 2.630% | 3.540% | 5.405% | 25.134% | 8.333% | -28.221% | -52.439% |
| Supernus Pharmaceuticals | -2.960% | -4.369% | -2.956% | 35.862% | -8.372% | 42.754% | 79.091% |
| Collegium Pharmaceutical Inc | -0.640% | 0.645% | -1.266% | 18.182% | -24.638% | 57.576% | 51.456% |
Comments
Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at JPMorgan Chase & Co. from $45.00 to $50.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PAHC provided by MarketBeat
Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at Bank of America Corporation from $19.00 to $27.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for PAHC provided by MarketBeat
Phibro Animal Health Corporation (NASDAQ: PAHC) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $35.00 price target on the stock, up previously from $25.00.
Show more
Ratings data for PAHC provided by MarketBeat